UnitedHealth Group reported strong Q1 results with robust revenue and earnings growth, along with raised earnings guidance for 2018. The positive performance of its Optum segments and strategic initiatives are likely to bolster investor confidence in the short term. This should support a positive movement in the stock price over the next couple of weeks.

[1]